Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2017-01-05

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2017-01-05 (fiscal Q3 2017): 37 published measures, 102 facts as tagged in accession 0001161697-17-000004.

This filing

Form
10-Q (quarterly report)
Filed
2017-01-05
Fiscal period
fiscal Q3 2017
Accession
0001161697-17-000004 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-11-308,474,852USD
At 2016-02-298,394,300USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-11-301,738,767USD
At 2016-02-291,276,001USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-11-306,736,085USD
At 2016-02-297,118,299USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-11-303,440,160USD
At 2016-02-294,201,949USD
At 2015-11-303,339,531USD
At 2015-02-282,557,235USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-09-01 to 2016-11-30-104,275USD91
2016-03-01 to 2016-11-30-420,204USD275
2015-09-01 to 2015-11-30167,552USD91
2015-03-01 to 2015-11-30438,126USD275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-03-01 to 2016-11-30137,182USD275
2015-03-01 to 2015-11-30106,337USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-11-302,599,736USD
At 2016-02-293,019,940USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-09-01 to 2016-11-3037,746,731shares91
2016-03-01 to 2016-11-3037,857,074shares275
2015-09-01 to 2015-11-3038,006,667shares91
2015-03-01 to 2015-11-3038,006,667shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-09-01 to 2016-11-3037,794,350shares91
2016-03-01 to 2016-11-3037,904,693shares275
2015-09-01 to 2015-11-3038,006,667shares91
2015-03-01 to 2015-11-3038,006,667shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-03-01 to 2016-11-30-0.01USD/shares275
2015-03-01 to 2015-11-300.01USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-03-01 to 2016-11-30-0.01USD/shares275
2015-03-01 to 2015-11-300.01USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-09-01 to 2016-11-30-53,216USD91
2016-03-01 to 2016-11-30-214,965USD275
2015-09-01 to 2015-11-3086,676USD91
2015-03-01 to 2015-11-30227,067USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-11-30933,947USD
At 2016-02-29996,822USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-03-01 to 2016-11-30157,245USD275
2015-03-01 to 2015-11-3038,360USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-09-01 to 2016-11-30-112,469USD91
2016-03-01 to 2016-11-30-601,029USD275
2015-09-01 to 2015-11-30290,215USD91
2015-03-01 to 2015-11-30718,132USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-11-307,118,837USD
At 2016-02-297,118,647USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-11-301,628,455USD
At 2016-02-291,107,914USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-11-30910,763USD
At 2016-02-29307,764USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2016-11-30390,578USD
At 2016-02-29247,691USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-11-301,661,214USD
At 2016-02-291,350,180USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-09-01 to 2016-11-302,176,412USD91
2016-03-01 to 2016-11-306,556,375USD275
2015-09-01 to 2015-11-301,819,064USD91
2015-03-01 to 2015-11-304,915,736USD275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-11-301,299,411USD
At 2016-02-291,040,277USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-09-01 to 2016-11-302,063,943USD91
2016-03-01 to 2016-11-305,955,346USD275
2015-09-01 to 2015-11-302,109,279USD91
2015-03-01 to 2015-11-305,633,868USD275

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-09-01 to 2016-11-302,034,016USD91
2016-03-01 to 2016-11-306,145,769USD275
2015-09-01 to 2015-11-301,698,226USD91
2015-03-01 to 2015-11-304,567,709USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-09-01 to 2016-11-3059,142USD91
2016-03-01 to 2016-11-30183,497USD275
2015-09-01 to 2015-11-3051,564USD91
2015-03-01 to 2015-11-30143,940USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-11-3037,749,081shares
At 2016-02-2937,966,501shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-11-302,194,454USD
At 2016-02-292,110,004USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-11-301,260,507USD
At 2016-02-291,113,182USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-11-3031,490USD
At 2016-02-2931,140USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-11-30582,998USD
At 2016-02-29499,406USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-09-01 to 2016-11-30-157,491USD91
2016-03-01 to 2016-11-30-635,169USD275
2015-09-01 to 2015-11-30254,228USD91
2015-03-01 to 2015-11-30665,193USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-09-01 to 2016-11-3083,254USD91
2016-03-01 to 2016-11-30227,109USD275
2015-09-01 to 2015-11-3069,274USD91
2015-03-01 to 2015-11-30204,087USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-09-01 to 2016-11-30454USD91
2016-03-01 to 2016-11-301,549USD275
2015-09-01 to 2015-11-30929USD91
2015-03-01 to 2015-11-303,058USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-09-01 to 2016-11-30-45,022USD91
2016-03-01 to 2016-11-30-34,140USD275
2015-09-01 to 2015-11-30-35,987USD91
2015-03-01 to 2015-11-30-52,939USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-03-01 to 2016-11-30294,066USD275
2015-03-01 to 2015-11-30134,196USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-03-01 to 2016-11-30259,134USD275
2015-03-01 to 2015-11-3032,165USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-03-01 to 2016-11-30602,998USD275
2015-03-01 to 2015-11-30279,122USD275

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))